세계의 수의 종양학 시장 보고서(2023년)

“Veterinary Oncology Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary oncology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The veterinary oncology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Therapy: Surgery; Radiology; Chemotherapy; Other Therapies

• 2) By Animal Type: Equine; Canine; Feline; Other Animal Types

• 3) By Cancer Type: Lymphoma; Mast Cell Cancer; Mammary And Squamous Cell Cancer; Other Cancer Types

• Companies Mentioned: PetCure Oncology; Zoetis Inc; Karyopharm Therapeutics Inc; Varian Medical Systems Inc.; Accuray Incorporated

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the veterinary oncology market are PetCure Oncology, Zoetis Inc, Karyopharm Therapeutics Inc, Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, One Health Company, Regeneus Ltd., VetDC Inc, Pharmaust Ltd., AdvaVet Inc., Nippon Zenyaku Kogyo Co. Ltd., Rhizen Pharmaceutical SA, and AB Science.

The global veterinary oncology market is expected to grow from $0.32 billion in 2022 to $0.36 billion in 2023 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary oncology market is expected to reach $0.55 billion in 2027 at a CAGR of 11.5%.

The veterinary oncology market includes revenues earned by entities by providing cryosurgery, comprehensive care, immunotherapy, and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions with sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals.

Asia-Pacific was the largest region in the veterinary oncology market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in veterinary oncolog report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of therapy in veterinary oncology are surgery, radiology, chemotherapy and others. Surgery refers to the technique to remove or repair a body part or to determine the presence of disease. The various animal types involved are equine, canine, feline, and others, that involve cancer types such as lymphomas, mast cell cancer, mammary and squamous cell cancer, and others.

The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body's cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused for cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the National Canine Cancer Foundation, a US-based foundation that strives to eliminate cancer in animals, in 2021, roughly 25% of purebred dogs pass away from cancer, with the probability of contracting the disease increasing to 45% for those over the age of ten. Furthermore, according to the National Library of Medicine, a US-based biomedical library, and the center of biomedical informatics, in 2021, approximately 4-6 million dogs are diagnosed with cancer in the 90 million total population of dogs in the US. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology market.

Product innovations are a key trend gaining popularity in the veterinary oncology market. Major companies operating in the veterinary oncology market are focused on developing new solutions to strengthen their position. For instance, in June 2021, PetDx, a US-based molecular diagnostics company dedicated to unleashing the power of genomics, launched "OncoK9," a novel multi-cancer early detection test. It is uniquely designed with the power of genomics to help veterinarians detect cancer in dogs earlier by using routine blood drawing without the need for prior fasting or sample processing. It processes the sample using proprietary methods optimized for canine cell-free DNA analysis and issues a digital report indicating if there is a cancer signal. It has strong clinical performance with minimal false-positive rates and high cancer diagnosis rates.

In July 2022, Zomedica Corp., a US-based veterinary health company that offers diagnostic and therapeutic products, acquired Assisi Animal Health LLC for an undisclosed amount. Through this acquisition, Zomedica Corp will combine resources with Assisi to enhance and strengthen Zomedica's product line, providing solutions that deliver enhanced companion animal care. Assisi Animal Health LLC, a US-based company, provides drug-free devices that reduce inflammation using targeted pulsed electromagnetic field (tPEMF) technology used to treat cancer in dogs.

The countries covered in the veterinary oncology market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The veterinary oncology market research report is one of a series of new reports from The Business Research Company that provides veterinary oncology market statistics, including veterinary oncology industry global market size, regional shares, competitors with veterinary oncology market share, detailed veterinary oncology market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary oncology industry. This veterinary oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Veterinary Oncology Market Characteristics

3. Veterinary Oncology Market Trends And Strategies

4. Veterinary Oncology Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Veterinary Oncology Market
• 4.2. Ukraine-Russia War Impact On Veterinary Oncology Market
• 4.3. Impact Of High Inflation On Veterinary Oncology Market

5. Veterinary Oncology Market Size And Growth

• 5.1. Global Veterinary Oncology Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Veterinary Oncology Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Veterinary Oncology Market Segmentation

• 6.1. Global Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Surgery
• Radiology
• Chemotherapy
• Other Therapies
• 6.2. Global Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Equine
• Canine
• Feline
• Other Animal Types
• 6.3. Global Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Lymphoma
• Mast Cell Cancer
• Mammary And Squamous Cell Cancer
• Other Cancer Types

7. Veterinary Oncology Market Regional And Country Analysis

• 7.1. Global Veterinary Oncology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Veterinary Oncology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Veterinary Oncology Market

• 8.1. Asia-Pacific Veterinary Oncology Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Veterinary Oncology Market

• 9.1. China Veterinary Oncology Market Overview
• 9.2. China Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Veterinary Oncology Market

• 10.1. India Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Veterinary Oncology Market

• 11.1. Japan Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Veterinary Oncology Market

• 12.1. Australia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Veterinary Oncology Market

• 13.1. Indonesia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Veterinary Oncology Market

• 14.1. South Korea Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Veterinary Oncology Market

• 15.1. Western Europe Veterinary Oncology Market Overview
• 15.2. Western Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Veterinary Oncology Market

• 16.1. UK Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Veterinary Oncology Market

• 17.1. Germany Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Veterinary Oncology Market

• 18.1. France Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Veterinary Oncology Market

• 19.1. Eastern Europe Veterinary Oncology Market Overview
• 19.2. Eastern Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Veterinary Oncology Market

• 20.1. Russia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Veterinary Oncology Market

• 21.1. North America Veterinary Oncology Market Overview
• 21.2. North America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Veterinary Oncology Market

• 22.1. USA Veterinary Oncology Market Overview
• 22.2. USA Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Veterinary Oncology Market

• 23.1. South America Veterinary Oncology Market Overview
• 23.2. South America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Veterinary Oncology Market

• 24.1. Brazil Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Veterinary Oncology Market

• 25.1. Middle East Veterinary Oncology Market Overview
• 25.2. Middle East Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Veterinary Oncology Market

• 26.1. Africa Veterinary Oncology Market Overview
• 26.2. Africa Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Veterinary Oncology Market Competitive Landscape And Company Profiles

• 27.1. Veterinary Oncology Market Competitive Landscape
• 27.2. Veterinary Oncology Market Company Profiles
  • 27.2.1. PetCure Oncology
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Zoetis Inc
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Karyopharm Therapeutics Inc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Varian Medical Systems Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Accuray Incorporated
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Veterinary Oncology Market

29. Veterinary Oncology Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer